OAB-053: Mezigdomide (MEZI; CC-92480) in combination with dexamethasone (DEX) and bortezomib (BORT) or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM)
Titel:
OAB-053: Mezigdomide (MEZI; CC-92480) in combination with dexamethasone (DEX) and bortezomib (BORT) or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM)
Auteur:
Richardson, Paul Sandhu, Irwindeep Oriol, Albert Raab, Marc S. White, Darrell LeBlanc, Richard Perrot, Aurore Ocio, Enrique Raje, Noopur Hansen, Charlotte Toftmann Zhou, Zehua Civardi, Tiziana Ghiddi, Alessandro Katz, Jessica Peluso, Teresa Dimopoulos, Meletios A.